Skip to main content
Premium Trial:

Request an Annual Quote

Shelley Glick; Jeff Wisotzkey; Kristina Habermann; Mike Adriani; Rob Gibbs

Genomind this week announced several new executives. Shelley Glick was named vice president of managed care; Jeff Wisotzkey has joined the company as lab director and VP of molecular pathology; Kristina Habermann is VP of marketing and corporate communications; and Mike Adriani was named SVP of information technology. Also, Rob Gibbs was promoted to the newly created position of chief commercial officer. 

Glick has more than 13 years of experience in the molecular diagnostics space and the medical device industry with a focus on managed care, payer relations, and health economics, Genomind said. Meanwhile, prior to joining the company, Wisotzkey was director of molecular pathology and technical director of laboratory operations at the Central Pennsylvania Alliance Laboratory. 

Habermann was in product management at PerkinElmer's diagnostics division before she joined Genomind, while Adriani was previously VP of IT at Plus Diagnostics. 

Gibbs has held leadership positions at Cigna and at Medecision in sales, marketing, finance, and operations.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.